TCTR20210216004已完成不适用
tility of the enzyme-linked immunospot interferon-gamma-release assay to predict the risk of infection in kidney transplant recipients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 15 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •All kidney transplant recipients
排除标准
- •Those who refused to join the study
研究者
相似试验
已完成
Unknown
Exploring the utility of enzyme-linked immunospot assays in previous COVID-19 and SARS-CoV-2 vaccinated individualsCOVID-19JPRN-UMIN000049834The Jikei University School of Medicine30
进行中（未招募）
4 期
rine Interferon Inducible Protein-10 Guided Treatment to Reduce Lupus Nephritis FlaresSystemic lupus erythemoatosus Lupus nephritisSystemic lupus erythemoatosusUrine interferon inducible protein-10Preemptive immunosuppressive treatmentLupus nephritisTCTR20190517004ational Science and Technology Development Agency216
进行中（未招募）
1 期
Antiviral and Immunomodulatory Interferon-Beta in high-risk COVID-19 patientsSARS-CoV 2 infection characterized by a National Early Warning Score lower or equal to 2 and symptoms present for less than 7 daysMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862MedDRA version: 20.0Level: PTClassification code 10070255Term: Coronavirus test positiveSystem Organ Class: 10022891 - InvestigationsEUCTR2020-003872-42-ITIstituto di Farmacologia Traslazionale - CNR60
已完成
不适用
Interferon (IFN) induction followed by PEG-interferon combined with ribavirin and amantadine for treatment of naive chronic hepatitis C patients with genotype 1 or 4Hepatitis C virus (HCV)Infections and InfestationsChronic viral hepatitisISRCTN59358441Academic Medical Centre (AMC) (Netherlands)58
招募中
不适用
Role and mechanism of type I interferon in the pathogenesis of anti-MDA5 antibody-positive dermatomyositisAnti-MDA5 antibody-positive dermatomyositisJPRN-UMIN000049776Chiba University150